Graham Abbott

High Times CEO Stormy Simon announced she is running for political office in her home state of Utah.

Australian researchers have uncovered evidence that a cannabis-based treatment could be effective against chronic insomnia.

Researchers have confirmed the effectiveness of a cannabis “tolerance break,” demonstrating that cannabis tolerance is linked to neurometabolic alterations in the brain’s reward circuitry.

Businesses that operate adjacent to the legal cannabis industry will be ineligible for the federal coronavirus loan assistance plan signed by President Trump last month.

The DEA has removed Epidiolex, the CBD-based epilepsy medication made by GW Pharmaceuticals, from the federal controlled substances list.

The first federal prisoner in the U.S. to die from the novel coronavirus was locked up on nonviolent drug charges.

Cannabis advocacy group Last Prisoner Project has launched a round-up change donation program for cannabis retailers that will aid the organization’s efforts to free all prisoners locked up on cannabis charges.

New York City-based Mind Medicine announced it had partnered with the world-leading psychedelics pharmacology and clinical research laboratory at University Hospital Basel in Switzerland.

Business analysts at DataTrek Research suggest more states could legalize adult-use cannabis in the near future to help their economies recover from the coronavirus pandemic.

Washington cannabis regulators have updated their guidelines for medical and adult-use cannabis dispensaries in the state after the governor issued a statewide shelter-in-place order.

With an increasing number of Americans seeking shelter at home, adult-use cannabis sales appear to have plummeted after a short period of intense stockpiling.

The DEA has unveiled a new rule proposal that would finally open up the licensing of new research-grade cannabis cultivators.

Steve DeAngelo, the founder of the Last Prisoner Project, issued a video statement calling for the release of all cannabis prisoners as the novel coronavirus spreads into the U.S. prison system.

Americans for Safe Access has issued a letter to state governors and medical cannabis program directors calling on the officials to make special allowances for medical cannabis patients amid the coronavirus outbreak.

Cannabis dispensaries in adult-use states have reported a surge in product sales as Americans prepare for self-quarantine and social distancing efforts aimed at curbing the spread of the coronavirus.

A study published last month shows that cannabis could be an effective and safer alternative treatment for fibromyalgia symptoms.

Two bills aiming to improve veterans’ access to medical cannabis have passed through the House Veterans’ Affairs Committee this week.

City officials in San Francisco could consider a freeze on new cannabis permits amid plummeting sales at individual dispensaries and a flourishing unregulated marketplace.

Under federal law, any consumer of cannabis cannot own or possess firearms; a recent ATF memo, however, seeks to strengthen those restrictions specifically against “habitual marijuana users.”

A recent study examined CBD’s effectiveness against the neurotoxicity of hydrogen peroxide (H₂O₂), a molecule that has been considered as a potential culprit in severe pathological conditions such as cancer, strokes, and neurodegenerative diseases.

The DEA admitted in a recent report to Congress that state-wide cannabis legalization policies have overall reduced demand in the illicit cannabis market.

The launch of Maine’s adult-use cannabis marketplace has been delayed for likely several months, with some officials predicting the first shop will open its doors in June.

MLB officials have announced that, while players are allowed to use cannabis in their personal lives, they are not allowed to partner with or accept sponsorships from cannabis companies.